Ipilimumab for Patients with Relapse after Allogeneic TransplantationMatthew S. Davids, Robert J. Soiffer, Rebecca Liguori et al.|New England Journal of Medicine|2016Cited by 595
A Multicenter Phase I/Ib Study of Ipilimumab for Relapsed Hematologic Malignancies after Allogeneic Hematopoietic Stem Cell TransplantationMatthew S. Davids, Robert J. Soiffer, Haesook T. Kim et al.|Blood|2015Cited by 11